However, serum Gas6 levels are increased in patients with advanced fibrosis and cirrhosis as well as in HCC patients, suggesting that excess Gas6 is able to overcome the feedback inhibition of sAxl [73,130], albeit, these data have to be confirmed in larger patient cohorts. The gene discussed is GAS6; the disease is Cirrhosis.